Blood eosinophil count and exacerbation risk in patients with COPD

European Respiratory Journal

Volumn 50, Issue 1, 2017, Pages

  Kerkhof, Marjan ^a   Sonnappa, Samatha ^a   Postma, Dirkje S ^b   Brusselle, Guy ^c,d   Agustí, Alvar ^e,f   Anzueto, Antonio ^g,h   Jones, Rupert ⁱ   Papi, Alberto ^j   Pavord, Ian ^k   Pizzichini, Emilio ^l   Popov, Todor ^m   Roche, Nicolas ^n,o   Ryan, Dermot ^p   Thomas, Mike ^q,r   Vogelmeier, Claus ^s,t   Chisholm, Alison ^u   Freeman, Daryl ^v   Bafadhel, Mona ^k   Hillyer, Elizabeth V ^a   Price, David B ^a,u,w  

^a OBSERVATIONAL AND PRAGMATIC RESEARCH INSTITUTE   (Singapore)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF BARCELONA   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g University of Texas Health Science Center   (United States)

^h SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

ⁱ PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^j UNIVERSITY OF FERRARA   (Italy)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^m MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

ⁿ UNIVERSITÉ PARIS DESCARTES   (France)

^o Institut Cochin   (France)

^p UNIVERSITY OF EDINBURGH   (United Kingdom)

^q UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^r UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^s UNIVERSITY HOSPITAL MARBURG   (Germany)

^t German Center of Lung Research (DZL)   (Germany)

^u Respiratory Effectiveness Group   (United Kingdom)

^v Mundesley Medical Centre   (United Kingdom)

^w UNIVERSITY OF ABERDEEN   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; BRONCHODILATING AGENT;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; COMORBIDITY; DIAGNOSTIC TEST; DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EOSINOPHIL COUNT; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HOSPITAL ADMISSION; HUMAN; LETTER; LONGITUDINAL STUDY; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; SMOKING; AGED; BLOOD; CYTOLOGY; EOSINOPHIL; FEMALE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK; VITAL CAPACITY;

AGED; BRONCHODILATOR AGENTS; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PATIENT ADMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RISK; SMOKING; VITAL CAPACITY;

EID: 85026266199     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00761-2017     Document Type: Letter

References (16)

1. Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: A randomized placebo-controlled trial. Am J Respir Crit Care Med 2012; 186: 48-55.
2. Pascoe S, Locantore N, Dransfield MT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: A secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med 2015; 3: 435-442.
3. Watz H, Tetzlaff K, Wouters EF, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: A post-hoc analysis of the WISDOM trial. Lancet Respir Med 2016; 4: 390-398.
4. UK National Health Service NHS. Full Blood Count. www.pathology.leedsth.nhs.uk/pathology/ClinicalInfo/Haematology/FullBloodCount.aspx Date last updated: April 25, 2013. Date last accessed: June 06, 2017.
5. Ver Hoef JM, Boveng PL. Quasi-Poisson vs. negative binomial regression: How should we model overdispersed count data?. Ecology 2007; 88: 2766-2772.
6. Global strategy for the diagnosis, management and prevention of COPD. Global initiative for chronic obstructive lung disease (GOLD), 2016. http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/Date last accessed: June 06, 2017.
7. Vedel-Krogh S, Nielsen SF, Lange P, et al. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population Study. Am J Respir Crit Care Med 2016; 193: 965-974.
8. Barnes NC, Sharma R, Lettis S, et al. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD. Eur Respir J 2016; 47: 1374-1382.
9. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999; 54: 1119-1138.
10. Faner R, Gonzalez N, Cruz T, et al. Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: Evidence of a gender effect. PLoS One 2014; 9: E97491.
11. Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis 2014; 9: 1145-1154.
12. van der Vaart H, Postma DS, Timens W, et al. Acute effects of cigarette smoke on inflammation and oxidative stress: A review. Thorax 2004; 59: 713-721.
13. van der Vaart H, Postma DS, Timens W, et al. Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir Res 2005; 6: 22.
14. Travers J, Marsh S, Caldwell B, et al. External validity of randomized controlled trials in COPD. Respir Med 2007; 101: 1313-1320.
15. Halpin DM, Kerkhof M, Soriano JB, et al. Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy. Respir Res 2016; 17: 120.
16. Karloh M, Fleig MA, Maurici R, et al. The COPD assessment test: what do we know so far?. A systematic review and meta-analysis about clinical outcomes prediction and classification of patients into GOLD stages. Chest 2016; 149: 413-425.